Gold prices steady ahead of Fed decision; weekly weakness noted
Investing.com - Scotiabank (TSX:BNS) downgraded Healthpeak Properties Inc (NYSE:DOC) from Sector Outperform to Sector Perform on Tuesday, while lowering its price target to $19.00. The stock, which has declined over 9% in the past week, currently offers a substantial 7.07% dividend yield, supported by 41 consecutive years of dividend payments according to InvestingPro data.
The downgrade follows weak second-quarter leasing performance and growing laboratory credit risk concerns for the healthcare real estate investment trust.
Scotiabank now forecasts a +1%/-1% compound annual growth rate for funds from operations per share (FFOPS) and adjusted funds from operations per share (AFFOPS) in 2026-2027, reduced from previous projections of +2%/+1%.
The bank cited lack of laboratory leasing progress at Healthpeak’s Vantage, Gateway/Directors, and Portside campuses in South San Francisco and San Diego, resulting in a slower development NOI commencement pace that will impact 2026-2027 earnings.
While Scotiabank acknowledged Healthpeak’s valuation appears historically discounted at 10.5x FY26 AFFOPS multiple for a high-quality portfolio, it sees "minimal positive catalysts on the horizon" with improvement in laboratory leasing remaining a key focus.
In other recent news, Healthpeak Properties released its second-quarter 2025 financial results, showing a mixed performance. The company reported earnings per share (EPS) of $0.05, which fell short of the anticipated $0.064, marking a 21.88% miss. On the brighter side, Healthpeak Properties’ revenue slightly exceeded expectations, coming in at $694.35 million compared to the forecasted $689.32 million. These developments have been closely watched by investors, especially given the earnings miss. The company’s financial performance highlights the challenges and opportunities within the healthcare real estate sector. Analysts and investors are likely to monitor future earnings reports to assess the company’s ability to meet or exceed market expectations.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.